Atherosclerosis

WASHINGTON — Finerenone was beneficial in primary and secondary prevention across the spectrum of patients with chronic kidney disease and type 2 diabetes regardless of whether they had atherosclerotic CVD, researchers reported.

Older adults had a 16% lower risk for developing parkinsonism after taking statins for 6 years compared with those not on statins, a report published in Neurology showed.

Adults with inflammatory bowel disease were more likely to have atherosclerotic CVD than those without it, according to study findings published in the American Journal of Preventive Cardiology.

Breast arterial calcification seen on a routine mammogram may independently predict atherosclerotic CVD and global CVD risk for postmenopausal women, according to research published in Circulation: Cardiovascular Imaging.

More intensive LDL cholesterol–lowering statin-based therapies may benefit patients with ischemic stroke with evidence of atherosclerosis, according to a meta-analysis published in JAMA Neurology.

Homozygous familial hypercholesterolemia, although rare, is frequently undertreated, especially in non-high-income countries, and is sometimes diagnosed after atherosclerosis or aortic stenosis is already present, researchers reported.

The virtual 2022 American College of Cardiology Scientific Session will be held from April 2 to 4, and will feature 25 late-breaking clinical trials, 10 featured clinical research presentations and numerous abstract presentations.

Aspirin use for primary atherosclerotic CVD prevention continues to be prevalent in adults aged 70 years or older despite contrary guideline recommendations, according to data published in the American Journal of Preventive Cardiology.

Exposure to toxic metals, including arsenic, cadmium and titanium, among employees at a car assembly plant was linked to subclinical level of atherosclerosis in three vascular territories, researchers reported.

Women and racial and ethnic minority groups were more likely to have substantial worsening of atherogenic lipid profiles during COVID-19 stay-at-home orders compared with before the pandemic, researchers reported.